References

Anzai T, Timoney JF, Kuwamoto Y, Fujita Y, Wada R, Inoue T. In vivo pathogenicity and resistance to phagocytosis of Streptococcus equi strains with different levels of capsule expression. Vet Microbiol. 1999; 67:(4)277-286 https://doi.org/10.1016/S0378-1135(99)00051-6

Bannister MF, Benson CE, Sweeney CR. Rapid species identification of group C streptococci isolated from horses. J Clin Microbiol. 1985; 21:(4)524-526 https://doi.org/10.1128/jcm.21.4.524-526.1985

Båverud V, Johansson SK, Aspan A. Real-time PCR for detection and differentiation of Streptococcus equi subsp. equi and Streptococcus equi subsp. zooepidemicus. Vet Microbiol. 2007; 124:(3-4)219-229 https://doi.org/10.1016/j.vetmic.2007.04.020

Bazeley PL. Studies with equine streptococci 2. Aust Vet J. 1940; 16:(6)243-259 https://doi.org/10.1111/j.1751-0813.1940.tb06315.x

Bazeley PL. Studies with equine streptococci 3. Aust Vet J. 1942a; 18:(4)141-155 https://doi.org/10.1111/j.1751-0813.1942.tb06344.x

Bazeley PL. Studies with equine streptococci 4. Aust Vet J. 1942b; 18:(5)189-194 https://doi.org/10.1111/j.1751-0813.1942.tb06359.x

Bazeley PL. Studies with equine streptococci 5. Aust Vet J. 1943; 19:(3)62-85 https://doi.org/10.1111/j.1751-0813.1943.tb04318.x

Bazeley PL, Battle J. Studies with equine streptococci 1. Aust Vet J. 1940; 16:(4)140-146 https://doi.org/10.1111/j.1751-0813.1940.tb01317.x

Björnsdóttir S, Harris SR, Svansson V Genomic dissection of an Icelandic epidemic of respiratory disease in horses and associated zoonotic cases. MBio. 2017; 8:(4) https://doi.org/10.1128/mBio.00826-17

Borst LB, Patterson SK, Lanka S, Barger AM, Fredrickson RL, Maddox CW. Evaluation of a commercially available modified-live Streptococcus equi subsp equi vaccine in ponies. Am J Vet Res. 2011; 72:(8)1130-1138 https://doi.org/10.2460/ajvr.72.8.1130

Boschwitz JS, Timoney JF. Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood. Infect Immun. 1994; 62:(8)3515-3520 https://doi.org/10.1128/iai.62.8.3515-3520.1994

Boyle AG, Smith MA, Boston RC, Stefanovski D. A case-control study developing a model for predicting risk factors for high SeM-specific antibody titers after natural outbreaks of Streptococcus equi subsp equi infection in horses. J Am Vet Med Assoc. 2017; 250:(12)1432-1439 https://doi.org/10.2460/javma.250.12.1432

Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles-revised consensus statement. J Vet Intern Med. 2018; 32:(2)633-647 https://doi.org/10.1111/jvim.15043

Boyle AG, Mitchell C, Stefanovski D, Waller AS. Horses vaccinated with live attenuated intranasal strangles vaccine seroconvert to SEQ2190 and SeM. Equine Vet J. 2022; 54:(2)299-305 https://doi.org/10.1111/evj.13443

Cursons R, Patty O, Steward KF, Waller AS. Strangles in horses can be caused by vaccination with Pinnacle I. N. Vaccine. 2015; 33:(30)3440-3443 https://doi.org/10.1016/j.vaccine.2015.05.009

Delph KM, Beard LA, Trimble AC, Sutter ME, Timoney JF, Morrow JK. Strangles, convalescent Streptococcus equi subspecies equi M antibody titers, and presence of complications. J Vet Intern Med. 2019; 33:(1)275-279 https://doi.org/10.1111/jvim.15388

Durham AE, Kemp-Symonds J. Failure of serological testing for antigens A and C of Streptococcus equi subspecies equi to identify guttural pouch carriers. Equine Vet J. 2021; 53:(1)38-43 https://doi.org/10.1111/evj.13276

El-Hage CM, Bannai H, Wiethoelter AK Serological responses of Australian horses using a commercial duplex indirect ELISA following vaccination against strangles. Aust Vet J. 2019; 97:(7)220-224 https://doi.org/10.1111/avj.12825

Flock M, Jacobsson K, Frykberg L Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses. Infect Immun. 2004; 72:(6)3228-3236 https://doi.org/10.1128/IAI.72.6.3228-3236.2004

Flock M, Karlström A, Lannergård J, Guss B, Flock J. Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse. Vaccine. 2006; 24:(19)4144-4151 https://doi.org/10.1016/j.vaccine.2006.02.016

Frosth S, Morris ERA, Wilson H Conservation of vaccine antigen sequences encoded by sequenced strains of Streptococcus equi subsp. equi. Equine Vet J. 2022; https://doi.org/10.1111/evj.13552

Galan JE, Timoney JF. Mucosal nasopharyngeal immune responses of horses to protein antigens of Streptococcus equi. Infect Immun. 1985a; 47:(3)623-628 https://doi.org/10.1128/iai.47.3.623-628.1985

Galan JE, Timoney JF. Immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of Streptococcus equi. J Immunol. 1985b; 135:(5)3134-3137

Galán JE, Timoney JF. Molecular analysis of the M protein of Streptococcus equi and cloning and expression of the M protein gene in Escherichia coli. Infect Immun. 1987; 55:(12)3181-3187 https://doi.org/10.1128/iai.55.12.3181-3187.1987

Guss B, Flock M, Frykberg L Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection. PLoS Pathog. 2009; 5:(9) https://doi.org/10.1371/journal.ppat.1000584

Hamlen HJ, Timoney JF, Bell RJ. Epidemiologic and immunologic characteristics of Streptococcus equi infection in foals. J Am Vet Med Assoc. 1994; 204:(5)768-775

Harris SR, Robinson C, Steward KF Genome specialization and decay of the strangles pathogen, Streptococcus equi, is driven by persistent infection. Genome Res. 2015; 25:(9)1360-1371 https://doi.org/10.1101/gr.189803.115

Hoffman AM, Staempfli HR, Prescott JF, Viel L. Field evaluation of a commercial M-protein vaccine against Streptococcus equi infection in foals. Am J Vet Res. 1991; 52:(4)589-592

Holden MTG, Heather Z, Paillot R Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog. 2009; 5:(3) https://doi.org/10.1371/journal.ppat.1000346

Hulting G, Flock M, Frykberg L, Lannergård J, Flock JI, Guss B. Two novel IgG endopeptidases of Streptococcus equi. FEMS Microbiol Lett. 2009; 298:(1)44-50 https://doi.org/10.1111/j.1574-6968.2009.01698.x

Jacobs AAC, Goovaerts D, Nuijten PJM, Theelen RPH, Hartford OM, Foster TJ. Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi. Vet Rec. 2000; 147:(20)563-567 https://doi.org/10.1136/vr.147.20.563

Jones FS. The Streptococci of Equines. J Exp Med. 1919; 30:(2)159-178 https://doi.org/10.1084/jem.30.2.159

Jonsson H, Lindmark H, Guss B. A protein G-related cell surface protein in Streptococcus zooepidemicus. Infect Immun. 1995; 63:(8)2968-2975 https://doi.org/10.1128/iai.63.8.2968-2975.1995

Karlström A, Jacobsson K, Flock M, Flock JI, Guss B. Identification of a novel collagen-like protein, SclC, in Streptococcus equi using signal sequence phage display. Vet Microbiol. 2004; 104:(3–4)179-188 https://doi.org/10.1016/j.vetmic.2004.09.014

Karlström A, Jacobsson K, Guss B. SclC is a member of a novel family of collagen-like proteins in Streptococcus equi subspecies equi that are recognised by antibodies against SclC. Vet Microbiol. 2006; 114:(1–2)72-81 https://doi.org/10.1016/j.vetmic.2005.10.036

Kelly C, Bugg M, Robinson C Sequence variation of the SeM gene of Streptococcus equi allows discrimination of the source of strangles outbreaks. J Clin Microbiol. 2006; 44:(2)480-486 https://doi.org/10.1128/JCM.44.2.480-486.2006

Kemp-Symonds J, Kemble T, Waller A. Modified live Streptococcus equi (‘strangles’) vaccination followed by clinically adverse reactions associated with bacterial replication. Equine Vet J. 2007; 39:(3)284-286 https://doi.org/10.2746/042516407X195961

Lanka S, Borst LB, Patterson SK, Maddox CW. A multiphasic typing approach to subtype Streptococcus equi subspecies equi. J Vet Diagn Invest. 2010; 22:(6)928-936 https://doi.org/10.1177/104063871002200612

Lannergård J, Frykberg L, Guss B. CNE, a collagen-binding protein of Streptococcus equi. FEMS Microbiol Lett. 2003; 222:(1)69-74 https://doi.org/10.1016/S03781097(03)00222-2

Lannergård J, Guss B. IdeE, an IgG-endopeptidase of Streptococcus equi ssp. equi. FEMS Microbiol Lett. 2006; 262:(2)230-235 https://doi.org/10.1111/j.15746968.2006.00404.x

Lindmark H, Jonsson P, Engvall E, Guss B. Pulsed-field gel electrophoresis and distribution of the geneszagandfnzin isolates of Streptococcus equi. Res Vet Sci. 1999; 66:(2)93-99 https://doi.org/10.1053/rvsc.1998.0250

Livengood JL, Lanka S, Maddox C, Tewari D. Detection and differentiation of wildtype and a vaccine strain of Streptococcus equi ssp. equi using pyrosequencing. Vaccine. 2016; 34:(34)3935-3937 https://doi.org/10.1016/j.vaccine.2016.06.035

McGlennon A, Waller A, Verheyen K Surveillance of strangles in UK horses between 2015 and 2019 based on laboratory detection of Streptococcus equi. Vet Rec. 2021; 189:(12) https://doi.org/10.1002/vetr.948

Meehan M, Nowlan P, Owen P. Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. equi. Microbiology. 1998; 144:(4)993-1003 https://doi.org/10.1099/00221287-144-4-993

Meehan M, Owen P, Lynagh Y, Woods C. The fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi additionally binds IgG and contributes to virulence in a mouse model. Microbiology. 2001; 147:(12)3311-3322 https://doi.org/10.1099/00221287-147-12-3311

Meehan M, Lewis MJ, Byrne C, O'Hare D, Woof JM, Owen P. Localization of the equine IgG-binding domain in the fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi. Microbiology. 2009; 155:(8)2583-2592 https://doi.org/10.1099/mic.0.028845-0

Mitchell C, Steward KF, Charbonneau ARL Globetrotting strangles: the unbridled national and international transmission of Streptococcus equi between horses. Microb Genom. 2021; 7:(3) https://doi.org/10.1099/mgen.0.000528

Newton JR, Wood JLN, Dunn KA, DeBrauwere MN, Chanter N. Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi. Vet Rec. 1997; 140:(4)84-90 https://doi.org/10.1136/vr.140.4.84

Newton JR, Verheyen K, Talbot NC Control of strangles outbreaks by isolation of guttural pouch carriers identified using PCR and culture of Streptococcus equi. Equine Vet J. 2000; 32:(6)515-526 https://doi.org/10.2746/042516400777584721

Parkinson NJ, Robin C, Newton JR, Slater J, Waller AS. Molecular epidemiology of strangles outbreaks in the UK during 2010. Vet Rec. 2011; 168:(25) https://doi.org/10.1136/vr.d1485

Pringle J, Venner M, Tscheschlok L, Waller AS, Riihimäki M. Markers of long term silent carriers of Streptococcus equi ssp. equi in horses. J Vet Intern Med. 2020; 34:(6)2751-2757 https://doi.org/10.1111/jvim.15939

Pusterla N, Watson JL, Affolter VK, Magdesian KG, Wilson WD, Carlson GP. Purpura haemorrhagica in 53 horses. Vet Rec. 2003; 153:(4)118-121 https://doi.org/10.1136/vr.153.4.118

Rendle D, de Brauwere MN, Hallowell G Streptococcus equi infections: current best practice in the diagnosis and managment of ‘strangles. UK-Vet Equine. 2021; 5:s1-s16 https://doi.org/10.12968/ukve.2021.5.2.S.3

Robinson C, Steward KF, Potts N Combining two serological assays optimises sensitivity and specificity for the identification of Streptococcus equi subsp. equi exposure. Vet J. 2013; 197:(2)188-191 https://doi.org/10.1016/j.tvjl.2013.01.033

Robinson C, Heather Z, Slater J Vaccination with a live multi-gene deletion strain protects horses against virulent challenge with Streptococcus equi. Vaccine. 2015; 33:(9)1160-1167 https://doi.org/10.1016/j.vaccine.2015.01.019

Robinson C, Frykberg L, Flock M, Guss B, Waller AS, Flock JI. Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi. Vaccine. 2018; 36:(11)1484-1490 https://doi.org/10.1016/j.vaccine.2018.01.030

Robinson C, Waller AS, Frykberg L Intramuscular vaccination with Strangvac is safe and induces protection against equine strangles caused by Streptococcus equi. Vaccine. 2020; 38:(31)4861-4868 https://doi.org/10.1016/j.vaccine.2020.05.046

De Medicina Equorum. 1251. http://wellcomelibrary.org/player/b19689755 (accessed 23 February 2022)

Sheoran AS, Artiushin S, Timoney JF. Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin. Vaccine. 2002; 20:(11–12)1653-1659 https://doi.org/10.1016/S0264-410X(01)00488-1

Steward KF, Robinson C, Maskell DJ, Nenci C, Waller AS. Investigation of the Fim1 putative pilus locus of Streptococcus equi subspecies equi. Microbiology. 2017; 163:(8)1217-1228 https://doi.org/10.1099/mic.0.000506

Thompson RN, McNicholl BP. Needlestick and infection with horse vaccine. BMJ Case Rep. 2010; 2010 https://doi.org/10.1136/bcr.11.2009.2444

Timoney JF, Kumar P. Early pathogenesis of equine Streptococcus equi infection (strangles). Equine Vet J. 2008; 40:(7)637-642 https://doi.org/:10.2746/042516408X322120

Timoney JF, Qin A, Muthupalani S, Artiushin S. Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi. Vaccine. 2007; 25:(30)5583-5590 https://doi.org/10.1016/j.vaccine.2007.02.040

Timoney JF, Yang J, Liu J, Merant C. IdeE reduces the bactericidal activity of equine neutrophils for Streptococcus equi. Vet Immunol Immunopathol. 2008; 122:(1–2)76-82 https://doi.org/10.1016/j.vetimm.2007.10.017

Turner CE, Kurupati P, Wiles S, Edwards RJ, Sriskandan S. Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi. Vaccine. 2009; 27:(36)4923-4929 https://doi.org/10.1016/j.vaccine.2009.06.042

Verheyen K, Newton JR, Talbot NC, Brauwere MN, Chanter N. Elimination of guttural pouch infection and inflammation in asymptomatic carriers of Streptococcus equi. Equine Vet J. 2000; 32:(6)527-532 https://doi.org/10.2746/042516400777584703

Waller A, Flock M, Smith K Vaccination of horses against strangles using recombinant antigens from Streptococcus equi. Vaccine. 2007; 25:(18)3629-3635 https://doi.org/10.1016/j.vaccine.2007.01.060

Waller AS. New perspectives for the diagnosis, control, treatment, and prevention of strangles in horses. Vet Clin North Am Equine Pract. 2014; 30:(3)591-607 https://doi.org/10.1016/j.cveq.2014.08.007

Webb K, Barker C, Harrison T Detection of Streptococcus equi subspecies equi using a triplex qPCR assay. Vet J. 2013; 195:(3)300-304 https://doi.org/10.1016/j.tvjl.2012.07.007

Woolcock JB. The capsule of Streptococcus equi. J Gen Microbiol. 1974; 85:(2)372-375 https://doi.org/10.1099/00221287-85-2-372

Unsaddling Streptococcus equi infection of horses

02 March 2022
14 mins read
Volume 6 · Issue 2
Figure 2. A foal showing the classic signs of strangles as a result of enlargement of abscesses in the lymph nodes, which are obstructing the airway.
Figure 2. A foal showing the classic signs of strangles as a result of enlargement of abscesses in the lymph nodes, which are obstructing the airway.

Abstract

Infection with Streptococcus equi, which forms abscesses in the lymph nodes of the head and neck in horses, is endemic in almost all countries around the world. The identification and isolation of horses with fever, an early sign of disease, is critical to minimising the number of horses affected and the severity of an outbreak, while the identification and treatment of persistently infected ‘carrier’ horses can reduce the risk of recurrent outbreaks and transmission between equine populations. Rapid diagnostic testing plays a key role in the identification of infected horses, which can then be isolated before the development of acute disease or treated to clear persistent infection. Vaccination can also be used to reduce the number of horses that become infected and the severity of their ensuing disease. This review describes the tools available to veterinarians and the journey towards the development and launch of a multi-component fusion protein vaccine that does not trigger positive diagnoses with any of the available diagnostic tests for strangles. The use of vaccination, alongside conventional methods of biosecurity and diagnostic testing, has the potential to unsaddle S. equi, reducing the number of strangles outbreaks and enhancing the health of horses.

Strangles, caused by Streptococcus subspecies equi (S. equi), was first described in 1251 by Jordanus Rufus (Ruffo, 1256). However, the disease remains endemic in horse populations throughout the world, with the notable exception of Iceland, where a ban on the import of horses has been in place for over 1000 years (Björnsdóttir et al, 2017; Mitchell et al, 2021). This article describes the mechanisms that underpin the transmission of S. equi and the tools available for preventing and resolving this important disease.

Horses become infected with S. equi via the nose or mouth, most likely through ingestion of contaminated food or water (Figure 1) (Boyle et al, 2018). The bacteria attaches to and invades the mucosal surface of the nasopharynx, using an array of ‘sticky’ proteins on its surface, including the collagen-binding protein, CNE, which is believed to stick out from the surface of S. equi on hair-like projections (Lannergård et al, 2003; Holden et al, 2009; Steward et al, 2017). However, S. equi does not colonise the nasopharynx and samples taken from recently infected horses and those incubating the disease often return a negative culture or polymerase chain reaction (PCR) result, confounding their diagnosis (Boyle et al, 2018; Rendle et al, 2021). Instead, S. equi translocates to the sub-mandibular and retropharyngeal lymph nodes within only a few hours of infection (Timoney and Kumar, 2008).

Register now to continue reading

Thank you for visiting UK-VET Equine and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.